Your browser is no longer supported. Please, upgrade your browser.
Settings
BSX Boston Scientific Corporation daily Stock Chart
BSX [NYSE]
Boston Scientific Corporation
IndexS&P 500 P/E419.65 EPS (ttm)0.06 Insider Own0.20% Shs Outstand1.36B Perf Week1.31%
Market Cap32.55B Forward P/E19.14 EPS next Y1.25 Insider Trans-10.00% Shs Float1.35B Perf Month12.51%
Income81.00M PEG33.74 EPS next Q0.29 Inst Own91.70% Short Float1.40% Perf Quarter4.82%
Sales8.17B P/S3.98 EPS this Y-98.30% Inst Trans0.05% Short Ratio2.12 Perf Half Y0.72%
Book/sh4.76 P/B5.03 EPS next Y13.53% ROA0.50% Target Price27.55 Perf Year36.14%
Cash/sh0.17 P/C137.32 EPS next 5Y12.44% ROE1.30% 52W Range15.67 - 24.79 Perf YTD10.59%
Dividend- P/FCF117.49 EPS past 5Y24.00% ROI0.70% 52W High-3.43% Beta1.07
Dividend %- Quick Ratio0.70 Sales past 5Y-0.90% Gross Margin71.30% 52W Low52.78% ATR0.39
Employees25000 Current Ratio1.10 Sales Q/Q11.50% Oper. Margin0.40% RSI (14)77.02 Volatility1.79% 1.58%
OptionableYes Debt/Eq0.84 EPS Q/Q213.70% Profit Margin1.00% Rel Volume0.90 Prev Close23.92
ShortableYes LT Debt/Eq0.80 EarningsFeb 02 BMO Payout0.00% Avg Volume8.89M Price23.94
Recom1.80 SMA207.09% SMA5010.72% SMA2006.40% Volume3,024,832 Change0.08%
Sep-01-16Upgrade Argus Hold → Buy
Jul-29-16Reiterated Wedbush Neutral $23 → $25
Jul-29-16Reiterated Needham Buy $26 → $28
Jul-28-16Reiterated The Benchmark Company Buy $25 → $31
Jun-09-16Initiated Guggenheim Buy
Apr-28-16Reiterated Wedbush Neutral $19 → $23
Apr-28-16Reiterated Stifel Buy $22 → $25
Apr-28-16Reiterated RBC Capital Mkts Outperform $22 → $25
Apr-28-16Reiterated Barclays Overweight $23 → $25
Apr-27-16Reiterated The Benchmark Company Buy $20 → $22
Apr-12-16Reiterated RBC Capital Mkts Outperform $20 → $22
Mar-17-16Initiated Nomura Buy
Feb-25-16Initiated Sun Trust Rbsn Humphrey Buy $21
Nov-12-15Initiated Citigroup Buy
Oct-28-15Reiterated Needham Buy $21 → $22
Oct-05-15Upgrade Raymond James Outperform → Strong Buy
Sep-28-15Upgrade Needham Hold → Buy $21
Aug-27-15Upgrade Goldman Neutral → Buy
Jul-23-15Reiterated The Benchmark Company Buy $19 → $20
May-04-15Reiterated Deutsche Bank Hold $17 → $19
Jan-19-17 08:00AM  Will Boston Scientific (BSX) Pull a Surprise in Q4 Earnings?
Jan-17-17 08:09AM  Analysts' Actions -- Chipotle, Disney, Brinker, J.P. Morgan and More
Jan-11-17 09:28AM  Boston Scientific Charts Appear Boston Strong
Jan-08-17 11:54PM  Parkinsons Therapy Gets Fresh Look From Device Makers at The Wall Street Journal
11:47AM  Parkinson's Therapy Gets Fresh Look From Device Makers at The Wall Street Journal
Jan-04-17 10:35AM  A Look at Becton Dickinsons Recent Stock Performance
Jan-03-17 04:14PM  Medtronic Downgraded On Increased Boston, J&J, St. Jude Rivalries
10:36AM  A Look at BDXs Recent Product Launches
08:30AM  Boston Scientific To Webcast Conference Call Discussing Fourth Quarter 2016 Financial Results And Announces 2017 Investor Day Business Review PR Newswire
Dec-30-16 12:35PM  St. Judes Proclaim Elite SCS System Received CE Mark Approval
11:05AM  How FDA Approval of EnSite Precision Will Benefit St. Judes
08:30AM  Boston Scientific To Participate In 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-29-16 09:19PM  Boston Scientific, Google look to jumpstart digital health startups at bizjournals.com
Dec-27-16 10:24AM  Boston Scientific Corp. Value Analysis (NYSE:BSX) : December 27, 2016
07:49AM  Boston Scientific Down on Risks; Innovations Raise Hope
Dec-26-16 09:06AM  Medtronics CoreValve Evolut R Expands Its Global Access
Dec-23-16 07:08AM  Boston Scientific Corp. breached its 50 day moving average in a Bullish Manner : BSX-US : December 23, 2016
Dec-22-16 11:44AM  These Billionaire Michael Prices Stock Picks Can Destroy Your Portfolio at Insider Monkey
Dec-20-16 07:35AM  Inside Edwards Lifesciences Financial Guidance for 2017
Dec-19-16 09:05AM  Where Is EWs SHV Therapy Segment Headed after Disappointing 3Q16 Sales?
Dec-16-16 09:06AM  Inside Edwards Lifesciences THV Product Pipeline and Future Growth Estimates
07:36AM  Edwards Lifesciences Riding High on TAVR Sales Growth and Future Opportunities
Dec-15-16 01:54PM  The Word on the Street: What Analysts Are Recommending for Edwards Lifesciences Now
Dec-14-16 08:24AM  Boston Scientific Acquires Neovasc to Boost Heart Business
Dec-13-16 07:35AM  [$$] Is Boston Scientific Nervous About Nevro? at Barrons.com
07:00AM  Neovasc and Boston Scientific Close US$75 Million Agreement CNW Group
07:00AM  Boston Scientific Closes Acquisition of Advanced Biological Tissue Capabilities and Acquires Common Shares of Neovasc, Inc. PR Newswire
Dec-09-16 05:22PM  Nevro Announces Filing of Lawsuit by Boston Scientific PR Newswire
Dec-08-16 02:05PM  Edwards Heart-Valve Guidance Lags On Medtronic, Boston Rivalry
Dec-07-16 11:20AM  Boston Scientific Corporation -- Moody's upgrades Boston Scientific's senior unsecured rating to Baa2; outlook is stable at Moody's
Dec-06-16 04:53PM  Edwards 2017 Guidance Likely Hinges On Rivalry With Medtronic, Boston
Dec-05-16 08:25AM  Analysts' Actions -- Boston Scientific, McDonald's, National Beverage, More
08:10AM  Boston Scientific (BSX) Inks $75 Million Deal with Neovasc
Dec-04-16 03:24PM  Barclays PLC (ADR) (BCS): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-02-16 04:22PM  Boston Scientific Acquisition Eyes Rivals Edwards, Medtronic
11:44AM  Boston Scientific Acquisition Eyes Rivals Edwards, Medtronic
08:05AM  Boston Scientific Completes Its Acquisition of EndoChoice
07:00AM  Neovasc and Boston Scientific Reach US$75 Million Agreement CNW Group
07:00AM  Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities PR Newswire
Dec-01-16 11:05AM  Trial Data Affirms Positive Results of HeartLogic Diagnostic Service
10:05AM  Nevro Lawsuit against BSX Could Impact Its Neuromodulation Revenues
08:06AM  In Focus: Boston Scientifics Stock Performance
Nov-30-16 06:30PM  What Do Analysts Recommend for Boston Scientific?
Nov-29-16 04:02PM  Boston Scientific Hit With Patent Lawsuit (BSX, NVRO) at Investopedia
11:04AM  What Really Disrupted Medtronics Diabetes Segment Sales in Fiscal 2Q17?
Nov-28-16 06:25PM  Nevro Files Lawsuit for Patent Infringement Against Boston Scientific in the U.S. PR Newswire
12:51PM  Medtronic Registers Missed Revenue Estimates Yet Again, Earnings in-Line
07:44AM  Boston Scientific Corporation (BSX): Are Hedge Funds Right about This Stock? at Insider Monkey
Nov-23-16 08:30AM  Boston Scientific To Participate In Citi 2016 Global Healthcare Conference PR Newswire
Nov-22-16 04:17PM  BOSTON SCIENTIFIC CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
09:58AM  As Medtronic Shares Plunge, This Analyst Says Buy On Weakness at Barrons.com
08:36AM  Boston Scientific Closes EndoChoice Acquisition PR Newswire
Nov-21-16 07:00AM  Boston Scientific Receives 2016 Shingo Prize for Operational Excellence PR Newswire
Nov-17-16 10:04AM  What Analysts Recommend for MDT ahead of Its Fiscal 2Q17 Results
08:05AM  Medtronics Fiscal 2Q17 Earnings Are Expected to Witness Growth
07:16AM  Boston Scientific (BSX) Reports Positive Data on HeartLogic
Nov-16-16 04:30PM  Boston Scientific To Participate In Piper Jaffray 2016 Healthcare Conference PR Newswire
02:13PM  Analyzing Medtronics Valuation before Its Fiscal 2Q17 Results
01:33PM  Boston Scientific Announces Positive Results Of HeartLogic Heart Failure Diagnostic Service PR Newswire
Nov-15-16 06:30AM  Boston Scientific Acquires Resectr Tissue Resection Device from Distal Access, LLC PR Newswire
Nov-11-16 01:00PM  Why Mead Johnson Nutrition CO (MJN), Boston Scientific Corporation (BSX), And 2 Other Stocks Might Be Right For Your Portfolio at Insider Monkey
Nov-10-16 01:04PM  BOSTON SCIENTIFIC CORP Financials
Nov-04-16 06:30AM  Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice PR Newswire
Nov-03-16 04:14PM  BOSTON SCIENTIFIC CORP Files SEC form 10-Q, Quarterly Report
06:30AM  Boston Scientific Announces Acquisition Of The LumenR Tissue Retractor System PR Newswire
Nov-02-16 09:43AM  Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN Left Atrial Appendage Closure Device PR Newswire
Nov-01-16 01:11PM  Primary Endpoint from Study of Drug Eluting Coronary Stent in Underserved Patient Populations Presented at TCT 2016 PR Newswire
Oct-31-16 10:19AM  Zimmer Biomet (ZBH) Posts In-Line Q3 Earnings, Guides Low
10:04AM  What Analysts Recommended for EW after Its 3Q16 Results
09:46AM  Omnicell (OMCL) Q3 Earnings Top, Revenues Miss Estimates
Oct-29-16 09:00AM  'Mad Money' Lightning Round: Smith and Wesson Represents Value, Cramer Says
Oct-28-16 02:52PM  ETFs with exposure to Boston Scientific Corp. : October 28, 2016
11:52AM  Analysts Recommendations for Boston Scientific
11:51AM  Boston Scientifics 3Q16 Earnings Beat Analysts Estimates
08:36AM  GNC Holdings (GNC) Q3 Earnings, Revenues Lag Estimates
Oct-27-16 09:47AM  Boston Scientific attracts cheap bets
09:32AM  NuVasive (NUVA) Earnings & Revenues Miss Estimates in Q3
09:30AM  Zacks.com featured highlights: LyondellBasell Industries N.V., Citrix Systems, Boston Scientific, Broadcom and ConAgra Foods
09:30AM  Abaxis (ABAX) Q2 Earnings & Revenues Miss, Margins Slide
09:05AM  Boston Scientific Corp. :BSX-US: Earnings Analysis: Q3, 2016 By the Numbers : October 27, 2016
08:30AM  Boston Scientific To Participate In Stifel 2016 Healthcare Conference PR Newswire
Oct-26-16 05:42PM  Edited Transcript of BSX earnings conference call or presentation 26-Oct-16 12:00pm GMT
02:32PM  Boston Scientific Shares Flat Following Mixed Earnings Results at TheStreet
10:45AM  Boston Scientific Remains Flat After Meeting Earnings
10:40AM  ResMed (RMD) Misses Earnings & Revenue Estimates in Q1
10:15AM  Boston Scientific's (BSX) Q3 Earnings in Line, Guides Up
09:39AM  Boston Scientific lifts 2016 revenue forecast after beat
09:30AM  Zacks.com featured highlights: AngioDynamics, Luxoft Holding, Boston Scientific, Popeyes Louisiana Kitchen and Thermo Fisher Scientific
08:37AM  Boston Scientific (BSX) Tops Revenue, Earnings in Line
08:19AM  [$$] Boston Scientific Raises Outlook at The Wall Street Journal
08:16AM  Boston Scientific (BSX) Stock Advances on Q3 Revenue Beat, Guidance
08:05AM  5 Top ROE Picks as Q3 Earnings Bells Chime
08:00AM  Boston Scientific Corp Earnings Call scheduled for 8:00 am ET today
07:07AM  Q3 2016 Boston Scientific Corp Earnings Release - Before Market Open
06:55AM  Boston Scientific beats sales estimates, raises full-year outlook at MarketWatch
06:48AM  Boston Scientific meets 3Q profit forecasts
06:42AM  BOSTON SCIENTIFIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
06:42AM  Medical device maker Boston Scientific's net sales rise 11.5 pct
06:30AM  Boston Scientific Announces Results For Third Quarter 2016 PR Newswire
05:23AM  Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pratt Timothy A.EVP, GC & Chief Admin OfficerJan 09Sale22.246,195137,769231,273Jan 10 04:06 PM
Pierce David ASVP and President, EndoscopyJan 09Sale22.2410,232227,54625,600Jan 10 04:08 PM
Bose SupratimEVP & President, Asia-PacificJan 03Option Exercise0.0014,9260276,598Jan 05 05:07 PM
Mahoney Michael FPresident & CEOJan 01Option Exercise0.00147,87301,664,964Jan 04 04:26 PM
Carruthers WendySVP, Human ResourcesJan 01Option Exercise0.0012,6460102,360Jan 04 04:19 PM
Ballinger Kevin J.SVP & Pres, Interven CardioJan 01Option Exercise0.0014,592062,951Jan 04 04:13 PM
Bose SupratimEVP & President, Asia-PacificJan 01Option Exercise0.0013,6190261,672Jan 04 04:13 PM
Brennan Daniel J.EVP and CFOJan 01Option Exercise0.0029,1850180,439Jan 04 04:14 PM
Nanavaty MaulikSVP & Pres, NeuromodulationJan 01Option Exercise0.0013,6190189,746Jan 04 04:30 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventJan 01Option Exercise0.0012,646084,271Jan 04 04:30 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJan 01Option Exercise0.0023,3470245,326Jan 04 04:40 PM
Pierce David ASVP and President, EndoscopyJan 01Option Exercise0.0015,565041,165Jan 04 04:40 PM
Phalen Michael P.EVP & President, MedSurgJan 01Option Exercise0.0017,5100107,596Jan 04 04:40 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerDec 01Option Exercise13.5618,761254,399260,430Dec 05 04:07 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeDec 01Option Exercise0.002,3270122,745Dec 05 04:07 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerDec 01Sale20.4826,726547,367233,704Dec 05 04:07 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerNov 01Option Exercise13.5617,000230,520266,421Nov 03 04:50 PM
Mahoney Michael FPresident & CEONov 01Option Exercise0.00341,67001,677,847Nov 03 04:54 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerNov 01Sale21.8924,752541,826241,669Nov 03 04:50 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeOct 29Option Exercise0.001,6960120,792Nov 01 04:09 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeOct 25Option Exercise0.003,6900119,908Oct 27 04:40 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerOct 03Option Exercise13.5617,000230,520273,421Oct 04 04:04 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerOct 03Sale23.5424,000564,970249,421Oct 04 04:04 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerSep 01Option Exercise13.5617,000230,520280,495Sep 06 04:08 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerSep 01Sale24.1024,074580,073256,421Sep 06 04:08 PM
Sorenson John BradleySVP, Manuf & Sup ChnAug 11Sale23.902,50059,75012,615Aug 15 07:43 AM
Pratt Timothy A.EVP, GC & Chief Admin OfficerAug 01Option Exercise13.5617,000230,520287,495Aug 02 04:10 PM
Mahoney Michael FPresident & CEOAug 01Sale24.4444,4001,084,9941,388,177Aug 02 04:12 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerAug 01Sale24.4624,000586,956263,495Aug 02 04:10 PM
Ballinger Kevin J.SVP & Pres, Interven CardioJul 20Option Exercise6.3178,122492,950125,092Jul 21 04:05 PM
Phalen Michael P.EVP & President, MedSurgJul 20Option Exercise12.5235,000438,200124,309Jul 20 04:29 PM
Pierce David ASVP and President, EndoscopyJul 20Option Exercise10.702,48026,53628,080Jul 20 04:30 PM
Pierce David ASVP and President, EndoscopyJul 20Sale24.032,48059,59425,600Jul 20 04:30 PM
Phalen Michael P.EVP & President, MedSurgJul 20Sale24.0335,000841,05089,309Jul 20 04:29 PM
Ballinger Kevin J.SVP & Pres, Interven CardioJul 20Sale24.0378,1221,877,27246,970Jul 21 04:05 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJul 01Option Exercise13.5617,000230,520294,495Jul 05 04:09 PM
Mahoney Michael FPresident & CEOJul 01Sale23.43100,0002,342,5701,432,577Jul 05 04:09 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJul 01Sale23.3924,000561,425270,495Jul 05 04:09 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJun 01Option Exercise13.5617,000230,520301,724Jun 03 07:58 AM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJun 01Sale22.6624,229548,976277,495Jun 03 07:58 AM
Mahoney Michael FPresident & CEOJun 01Sale22.69100,0002,268,6501,532,577Jun 03 07:57 AM
Sorenson John BradleySVP, Manuf & Sup ChnMay 11Sale22.152,80062,02015,115May 12 04:07 PM
Dawkins Keith DEVP, Global Chief Med. Off.May 10Sale22.1580,0001,772,224150,227May 12 04:06 PM
Fitzgerald Joseph MichaelEVP & President, CRMMay 03Sale21.8179,9601,743,53692,020May 04 04:26 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerMay 02Option Exercise13.5617,000230,520308,724May 03 04:11 PM
Mahoney Michael FPresident & CEOMay 02Sale22.12100,0002,212,2701,632,577May 03 04:12 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerMay 02Sale21.9324,000526,438284,724May 03 04:11 PM
Ballinger Kevin J.SVP & Pres, Interven CardioApr 27Option Exercise9.09111,8071,015,979158,777Apr 28 04:22 PM
Pierce David ASVP and President, EndoscopyApr 27Option Exercise8.3016,512137,05042,112Apr 28 04:26 PM
Phalen Michael P.EVP & President, MedSurgApr 27Option Exercise12.5235,000438,200124,309Apr 28 04:33 PM
Phalen Michael P.EVP & President, MedSurgApr 27Sale22.0035,000770,00089,309Apr 28 04:33 PM
Pierce David ASVP and President, EndoscopyApr 27Sale21.6916,512358,16225,600Apr 28 04:26 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerApr 27Sale21.4039,927854,438291,724Apr 28 04:29 PM
Ballinger Kevin J.SVP & Pres, Interven CardioApr 27Sale21.62111,8072,416,77546,970Apr 28 04:22 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventApr 04Sale19.0018,422350,01896,634Apr 05 04:33 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerApr 01Option Exercise13.5617,000230,520355,651Apr 05 04:35 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerApr 01Sale18.7324,000449,462331,651Apr 05 04:35 PM
Ballinger Kevin J.SVP & Pres, Interven CardioMar 11Sale18.0016,705300,69046,970Mar 14 04:10 PM
Pierce David ASVP and President, EndoscopyMar 08Sale17.2751,763894,18525,600Mar 08 04:16 PM
Prange KarenSVP&Pres, Uro & Pelvic HealthMar 08Sale17.2714,747254,74938,395Mar 08 04:13 PM
Mackey Edward FEVP, OperationsMar 02Option Exercise0.0019,226020,655Mar 03 04:11 PM
Phalen Michael P.EVP & President, MedSurgMar 02Sale17.1710,665183,10389,309Mar 02 04:10 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerMar 01Sale16.9715,068255,755338,651Mar 02 04:13 PM
Mahoney Michael FPresident & CEOMar 01Sale16.96100,0001,695,6001,832,577Mar 02 04:07 PM
Phalen Michael P.EVP & President, MedSurgFeb 29Sale17.191,81931,27299,974Mar 01 04:32 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 29Sale17.172,11436,29763,675Mar 01 04:17 PM
Pierce David ASVP and President, EndoscopyFeb 28Option Exercise0.007,890081,080Mar 01 04:35 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 28Option Exercise0.008,555020,790Mar 01 04:38 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 28Option Exercise0.009,5810176,599Mar 01 04:27 PM
Mahoney Michael FPresident & CEOFeb 28Option Exercise0.0050,74401,956,478Mar 01 04:27 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 28Option Exercise0.005,6530177,689Mar 01 04:32 PM
Phalen Michael P.EVP & President, MedSurgFeb 28Option Exercise0.0013,7940108,291Mar 01 04:32 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 28Option Exercise0.007,9110118,870Mar 01 04:27 PM
Carruthers WendySVP, Human ResourcesFeb 28Option Exercise0.006,513092,783Mar 01 04:22 PM
Brennan Daniel J.EVP and CFOFeb 28Option Exercise0.005,4980155,896Mar 01 04:22 PM
Bose SupratimEVP & President, Asia-PacificFeb 28Option Exercise0.006,7660248,053Mar 01 04:19 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 28Option Exercise0.0011,338071,254Mar 01 04:17 PM
Pierce David ASVP and President, EndoscopyFeb 27Option Exercise0.003,185074,691Mar 01 04:35 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 27Option Exercise0.007,166014,641Mar 01 04:38 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 27Option Exercise0.005,9720169,897Mar 01 04:27 PM
Mahoney Michael FPresident & CEOFeb 27Option Exercise0.0057,32501,932,735Mar 01 04:27 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 27Option Exercise0.002,3890173,099Mar 01 04:32 PM
Phalen Michael P.EVP & President, MedSurgFeb 27Option Exercise0.006,370097,498Mar 01 04:32 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 27Option Exercise0.002,3890112,111Mar 01 04:27 PM
Carruthers WendySVP, Human ResourcesFeb 27Option Exercise0.004,618088,446Mar 01 04:22 PM
Brennan Daniel J.EVP and CFOFeb 27Option Exercise0.002,5880151,617Mar 01 04:22 PM
Bose SupratimEVP & President, Asia-PacificFeb 27Option Exercise0.003,1850241,287Mar 01 04:19 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 27Option Exercise0.003,185061,452Mar 01 04:17 PM
Brennan Daniel J.EVP and CFOFeb 25Sale17.483,62063,278149,029Feb 26 04:29 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 25Sale17.481,90333,26458,267Feb 26 04:21 PM
Brennan Daniel J.EVP and CFOFeb 24Option Exercise7.2392,496668,555254,941Feb 26 04:29 PM
Bose SupratimEVP & President, Asia-PacificFeb 24Option Exercise0.002,6760238,102Feb 26 04:26 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 24Option Exercise0.002,867061,552Feb 26 04:21 PM
Carruthers WendySVP, Human ResourcesFeb 24Option Exercise0.002,484084,998Feb 26 04:30 PM
Brennan Daniel J.EVP and CFOFeb 24Sale17.2199,5911,713,961152,649Feb 26 04:29 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 23Option Exercise0.001,53207,137Feb 25 04:36 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 23Option Exercise0.009190105,257Feb 25 04:37 PM
Prange KarenSVP&Pres, Uro & Pelvic HealthFeb 23Option Exercise0.002,299051,064Feb 25 04:34 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 23Option Exercise0.003,6780353,954Feb 25 04:34 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 23Option Exercise0.001,8390169,732Feb 25 04:28 PM